Effects of saline extract of ovine hydatid Cyst scoleces in Sheep

Similar documents
Diurnal variation in microfilaremia in cats experimentally infected with larvae of

Alfaxan. (alfaxalone 10 mg/ml) Intravenous injectable anesthetic for use in cats and dogs. TECHNICAL NOTES DESCRIPTION INDICATIONS

Summary of Product Characteristics

Anesthesia Check-off Form

SUMMARY OF PRODUCT CHARACTERISTICS

BOX 1. NAME OF THE VETERINARY MEDICINAL PRODUCT. Hymatil 300 mg/ml solution for injection for cattle and sheep Tilmicosin

PHYSICIAN ORDERS. Page 1 of 6. Provider Initial: Esophagectomy Preoperative [ ] Height Weight Allergies

Candidate Name: PRACTICAL Exercise Medications & Injections

SUMMARY OF PRODUCT CHARACTERISTICS

SOME OBSERVATIONS ON PECKING IN PIGEONS

DISSOCIATIVE ANESTHESIA

T u l a n e U n i v e r s i t y I A C U C Guidelines for Rodent & Rabbit Anesthesia, Analgesia and Tranquilization & Euthanasia Methods

SUMMARY OF PRODUCT CHARACTERISTICS. Euthasol vet. 400 mg/ml, solution for injection (AT, BE, DK, EE, EL, FI, IE, IS, LT, LU, LV, NO, PL, RO SE, UK)

Final Report. Project code: P.PSH.0653 Prepared by: Fiona Cotter Troy Laboratories Pty Ltd Date published: July 2014

SUMMARY OF PRODUCT CHARACTERISTICS

SUMMARY OF PRODUCT CHARACTERISTICS

SUMMARY OF PRODUCT CHARACTERISTICS

1. NAME AND ADDRESS OF THE MARKETING AUTHORISATION HOLDER AND OF THE MANUFACTURING AUTHORISATION HOLDER RESPONSIBLE FOR BATCH RELEASE, IF DIFFERENT

SUMMARY OF PRODUCT CHARACTERISTICS. Narcostart 1 mg/ml solution for injection for cats and dogs (NL, AT, BE, CZ, EL, HU, IS, LU, PL, SK)

HYDATID CYST DISEASE

Article available at or

EXCEDE Sterile Suspension

SUMMARY OF PRODUCT CHARACTERISTICS

6/10/2015. Multi Purpose Canine (MPC) Restraint and Physical Examination PFN: Terminal Learning Objective. Hours: Instructor:

ANNEX I SUMMARY OF PRODUCT CHARACTERISTICS

Jeff Baier MS DVM Birds of Prey Foundation Broomfield, CO

the same safe, reliable sedation and analgesia as DEXDOMITOR. specifically made for cats that weigh 7 lb or less.

What causes heartworm disease?

Efficacy of Moxidectin 6-Month Injectable and Milbemycin Oxime/Lufenuron Tablets Against Naturally Acquired Toxocara canis Infections in Dogs*

Mouse Formulary. The maximum recommended volume of a drug given depends on the route of administration (Formulary for Laboratory Animals, 3 rd ed.

SUMMARY OF PRODUCT CHARACTERISTICS. Pentoject, Pentobarbitone Sodium 200 mg/ml Solution for Injection

TELAZOL (tiletamine and zolazepam for injection) IV Induction Claim FAQs 1, 2

SUMMARY OF PRODUCT CHARACTERISTICS. NUFLOR 300 mg/ml solution for injection for cattle and sheep

Dexmedetomidine. Dr.G.K.Kumar,M.D.,D.A., Assistant Professor, Madras medical college,chennai. History

Preanesthesia in dogs Dog Weight. Sedation/analgesia in dogs Dog Weight. Sedation/analgesia and preanesthesia in cats

Australian and New Zealand College of Veterinary Scientists. Membership Examination. Veterinary Anaesthesia and Critical Care Paper 1

Summary of Product Characteristics

Canine Dosing Chart DEXDOMITOR

ANNEX I SUMMARY OF PRODUCT CHARACTERISTICS

Irish Medicines Board

GUIDELINES FOR ANESTHESIA AND FORMULARIES

CANINE HEARTWORM DISEASE

Earn a rebate on pioneering brands you trust.

Fluid Therapy and Heat Injuries in Multi Purpose Canines (MPC) PFN: SOMVML0R. Terminal Learning Objective. References. Hours: Instructor:

COMMITTEE FOR VETERINARY MEDICINAL PRODUCTS

Australian and New Zealand College of Veterinary Scientists. Fellowship Examination. Veterinary Anaesthesia and Critical Care Paper 1

ANNEX III AMENDMENTS TO THE SUMMARY OF PRODUCT CHARACTERISTICS AND PACKAGE LEAFLET

PRESCRIPTION ANIMAL REMEDY KEEP OUT OF REACH OF CHILDREN FOR ANIMAL TREATMENT ONLY ILIUM PROPERCILLIN ANTIBIOTIC INJECTION

Day 90 Labelling, PL LABELLING AND PACKAGE LEAFLET

Heartworm Disease in Dogs

Cepesedan 10 mg/ml, Solution for Injection for Horses and Cattle

1 iv. 00 lad I 00 EDGEW00D ARSENAL ^ TECHNICAL REPORT. DOSE-RESPONSE RELATIONSHIP OF CRUDE COBRA VENOM {Naja naja) IN THE DOG

SUMMARY OF PRODUCT CHARACTERISTICS

TOXOIDING OF SNAKE VENOM AND EVALUATION OF IMMUNOGENICITY OF THE TOXOIDS

Drug therapy of Filariasis. Dr. Shareef sm Asst. professor pharmacology

Summary of Product Characteristics

Summary of Product Characteristics

The effect of environmental temperature on the growth of vertebrae in the tail of the mouse

Withdrawal period: 93 days Milk: Not authorised for use in animals producing milk for human consumption.

THE EFFECT OF MUTILATION ON THE TAPEWORM TAENIA TAENIAEFORMIS

A New Advancement in Anesthesia. Your clear choice for induction.

ANNEX I SUMMARY OF PRODUCT CHARACTERISTICS

COMMITTEE FOR MEDICINAL PRODUCTS FOR VETERINARY USE

HIGH DENSITY DIETS FOR DWARF LAYERS (1)

Health Products Regulatory Authority

1. NAME OF THE VETERINARY MEDICINAL PRODUCT

Role of "-Adrenoreceptors In The Regulation of Fore-Stomach Motility in the Goat

Feline blood transfusions: preliminary considerations

Metacam 1.5 mg/ml oral suspension for dogs

Proceedings of the 36th World Small Animal Veterinary Congress WSAVA

Period of study: 12 Nov 2002 to 08 Apr 2004 (first subject s first visit to last subject s last visit)

[Version 8.1, 01/2017] APPENDIX I SUMMARY OF PRODUCT CHARACTERISTICS

EVALUATION OF THE EFFICACY OF CYCOSTAT 66G AGAINST COCCIDIOSIS IN FATTENING RABBITS UNDER CONTROLLED FIELD CONDITIONS.

Oxygenation in Medetomidine-Sedated Dogs with and without 100% Oxygen Insufflation

STANDARD OPERATING PROCEDURE #111 RAT ANESTHESIA

Gye and Cramer (1919) found that the ionizable salts of calcium injected together with the washed spores of Cl. tetani or of certain

ANNEX I SUMMARY OF PRODUCT CHARACTERISTICS VIRBAGEN OMEGA - EN 1

Antibiotic Prophylaxis in Spinal Surgery Antibiotic Guidelines. Contents

This is the smallest tapeworm that can affect human being but it s not really proper human tapeworm (the human is not the primary host).

BOVINE RESPIRATORY DISEASE COMPLEX. Kristen Mierzwiak LCS 630

EXOTIC SMALL MAMMAL ANESTHETIC TECHNIQUES

Canine Spay and Neuter Services At Manzini Animal Hospital

B. PACKAGE LEAFLET 1

STANDARD OPERATING PROCEDURE #110 MOUSE ANESTHESIA

Hydatid Cyst Dr. Nora L. El-Tantawy

SUMMARY OF PRODUCT CHARACTERISTICS

ENVIRACOR J-5 aids in the control of clinical signs associated with Escherichia coli (E. coli) mastitis

Summary of Product Characteristics

Summary of Product Characteristics

Gastric Dilatation-Volvulus

Procedure # IBT IACUC Approval: December 11, 2017

DEPARTMENT OF THE ARMY South Plains District Veterinary Command North Texas Branch Fort Hood, TX FH-VTF FEB 2009

TREATMENT OF ANOESTRUS IN DAIRY CATTLE R. W. HEWETSON*

Non-invasive, mildly to moderately painful, procedures and examinations which require restraint, sedation and analgesia in dogs and cats.

Schistosoma mansoni, S. japonicum, S. haematobium

ANNEX I SUMMARY OF PRODUCT CHARACTERISTICS. Medicinal product no longer authorised

Malignant Catarrhal Fever in a Red Angus Cow B Y : L A U R E N R I C E R O V C

1941 ) would suggest genetic differences between breeds with respect to these

Tiletamine-Zolazepam anesthesia in horses : repeated dose versus continuous infusion

ANNEX I SUMMARY OF PRODUCT CHARACTERISTICS

Transcription:

Masson, Paris, 1980 Annales de Parasitologie (Paris) 1980, t. 55, n 5, pp. 503-510 Effects of saline extract of ovine hydatid Cyst scoleces in Sheep Blockade of responses by compound 48/80 (*) by M. TABATABAI, M. VESSAL and N. COHAMM Departments of Physiology and Biochemistry, School of Medicine, Shiraz University, Shiraz, Iran. SUMMARY. The effects of intravenous administration of the saline extract of the ovine hydatid cyst scoleces on the cardiovascular and respiratory systems were studied in sodium pentobarbital-anesthesized sheep. Scoleces were obtained from the lung hydatid cysts of freshly slaughtered sheep, sonicated in physiologic saline and centrifuged to recover the extract in the supernatant fluid. Administration of 1-4 ml of the saline extract resulted in hypotension, shallow rapid respiration, slight elevation of the central venous pressure and transient electrocardiographic changes. Pretreatment of the animals with atropine, 1 mg/kg S.C., or with the antihistamine antazoline, 5 mg/kg I.V., dit not block the responses to the saline extract of the hydatid cyst scoleces. Pretreatment with compound 48/80, a histamine releaser, abolished the reactions to the administration of the scoleces extract. It is concluded that ovine hydatid scoleces extract has profound cardiovascular and respiratory effects, and that histamine release seems to be involved in the induction of responses to the extract. (*) This investigation was supported, in part, by a grant from the Shiraz University, Shiraz, Iran. Accepté le 26 février 1980. Article available at http://www.parasite-journal.org or https://doi.org/10.1051/parasite/1980555503

504 M. TABATABAI, M. VESSAL AND N. COHANIM Effet d extrait salin de scolex de kystes hydatiques ovins sur le mouton. RESUME. Les effets de l injection intra-veineuse d extrait salin de scolex de kystes hydatiques ovins sur les systèmes cardiovasculaire et respiratoire ont été étudiés chez des moutons anesthésiés au pentobarbital sodique. Les scolex de kystes hydatiques pulmonaires de moutons fraîchement sacrifiés ont été soniqués dans du sérum physiologique et centrifugés afin de recueillir l extrait contenu dans le supernatant. L administration de 1 à 4 ml d extrait salin a entraîné un effondrement de la tension artérielle, une accélération du rythme respiratoire, une légère élévation de la pression veineuse centrale ainsi que des modifications transitoires de l électrocardiogramme. Le prétraitement des animaux avec de l atropine (1 mg/kg) injectée par voie souscutanée ou avec l antihistamine antazoline (5 mg/kg) injectée par voie intra-veineuse n a pas aboli la réaction à l administration d extrait salin de scolex de kystes hydatiques. Le prétraitement des animaux avec le produit 48/80, qui induit la libération d histamine, supprime les réactions produites par l injection d extrait de scolex. En conclusion, l injection d extrait de scolex hydatiques ovins entraîne des réactions cardiovasculaires et respiratoires sérieuses et la libération d histamine semble être liée à l induction de ces réponses. Introduction Rupture of the hydatid cyst in man may cause dyspnea, cyanosis, vomiting, diarrhea, circulatory shock and sudden death (1, 3, 5). Experimentally, administration of the ovine hydatid fluid to laboratory animals such as cats, dogs and sheep produces hypotension, cardiac arhythmia, rapid respiration and death (6-10). Within the hydatid cyst, there are scoleces whose products contribute to the hydatid fluid contents. In the present investigation, the effects of the saline extract of the hydatid scoleces on the cardiovascular and respiratory systems of sheep were studied. The responses were blocked by pretreatment of the animals with compound 48/80, indicating the role of histamine in the mediation of the reactions to the extract. Materials and methods Thirty sheep, weighing 23-28 kg, were anesthetized with sodium pentobarbital 25 mg/kg I.V. Arterial blood pressure (ABP), central venous pressure (CVP), electrocardiogram (ECG) and respiration were recorded on a Grass polygraph (Grass Instrument Co., Quincy, Mass.). All the intravenous injections were administered through the catheter used for the measurement of the CVP.

EFFECTS OF HYDATID SCOLECES EXTRACT IN SHEEP 505 The animals could be tested more than once, each test 48 hours or more apart. At the beginning of each test, the baseline ABP, respiration and ECG were checked to ensure that the sheep has recovered from the previous operation and test. At the end of the tests, the animals were killed by giving lethal doses of the anesthetic, and the liver and lungs were grossly examined for the presence of hydatid cysts. Preparation of saline scolex extract: Saline scolex extract was prepared by sonicating the scoleces (2 grams in 20 ml 0.9 % sodium chloride solution) for 30 minutes in a Bronswill sonic oscillator. The scoleces were obtained from the lung hydatid cysts of sheep freshly slaughtered. The sonicated solution was centrifuged and the supernatant fluid, containing the extract was removed and mixed with 0.9 % sodium chloride solution. The final saline extract contained 400 mg protein per 100 ml. The animals received 1-4 ml of this solution intravenously. Physiologic sodium chloride solution (0.9 %) was used as the control solution. Pretreatment with atropine, antazoline and compound 48/80: Five sheep with cardiovascular and respiratory responses to scolex extract during the first test were pretreated with atropine, 1 mg/kg subcutaneously, during the second test 20 minutes before administration of the scolex extract. The anticholinergic effect of atropine was tested against intravenous injection of acetylocholine, 10 μg/kg. Five other sheep which developed respiratory and cardiovascular responses to the scolex extract during the first test were pretreated with the antihistamine antazoline, 5 mg/kg I.V., 2-5 minutes before injection of scolex extract during the second test. The antihistaminic effect of antazoline was assessed against intravenous injection of histamine, 5 μg/kg I.V. Five other sheep with cardiovascular and respiratory responses to the scolex extract during the first test were given compound 48/80, a histamine releaser (4), during the second test before administration of the extract. The amount given was 0.05 mg/kg I.V. The response to the compound was a transient precipitous fall in the ABP and shallow rapid respiration. The compound was repeated every 30 minutes until there was no more response to the compound, at which time the animal was considered histamine depleted. Results Cardiovascular responses: Administration of 1-4 ml extract solution caused diminution of the ABP in 27 sheep (90 %), of which six (20 % of the total) died. Among the surviving ones, the mean ABP of 108 mm Hg decreased to 60 mm Hg, the difference being statistically significant (P < 0.01). ABP returned to the preinjection value in 1-5 minutes. Subsequent injections of equal volumes of the same extract solution during the same test evoked either a lesser hypotensive response

506 M. TABATABAI, M. VESSAL AND N. COHANIM or none at all (fig. 1). However, 48 hours or more later, during the second test, the magnitude of the hypotensive response to the extract was equal to or more than that observed during the first test. Other cardiovascular responses were slight elevation of the CVP (1-3 cm H20), frequent decrease or occasional increase in the heart rate and ECG changes. The latter consisted of flattening or inversion of the T wave, premature atrial and/or ventricular contractions, and ST segment depression. The ECG changes were transient and disappeared 2-3 minutes after return of the ABP to normal. Respiratory responses: All the 27 sheep with cardiovascular responses to the scolex extract developed respiratory changes as well. In 20 sheep, respiration became fast and shallow (fig. 1) and in 7, fast and slightly deep (fig. 2). It took 10 to 15 minutes for respiration to return to the preinjection state. Occasionally there were short periods of apnea (10-30 seconds) interposed between the tachypneic phases. Fig. 1. Effect of intravenous injection of 1ml of the saline extract of the hydatid cyst scoleces on the arterial blood pressure (ABP), central venous pressure (CVP) and respiration. In Panel A (left side), the ABP dropped, the CVP slightly rose and respiration became shallow and fast. Fifteen minutes later (Panel B, right side), on second injection of the extract, only slight change in ABP developed while CVP and respiration did not change.

EFFECTS OF HYDATID SCOLECES EXTRACT IN SHEEP 507 Among the animals which died after the scolex extract injection, respiration gradually slowed down and finally ceased. Artificial respiration by pressing upon the chest failed to resuscitate them. Effect of pretreatment with atropine: Pretreatment with atropine (1 mg/kg S.C.) did not abolish the responses to the scolex extract (fig. 2), although it blocked the hypotensive effect of the intravenous injection of 10 μg/kg acetylcholine. Effect of pretreatment with antazoline: Pretreatment with the antihistamine antazoline (5 mg/kg I.V.) did not prevent the reactions to the extract (fig. 5), though it prevented the cardiovascular and respiratory responses to intravenous injection of 5 μg/kg histamine. Fig. 2. Pretreatment with atropine fails to prevent responses to hydatid scoleces extract.

508 M. TABATABAI, M. VESSAL AND N. COHANIM Fig. 3. Arterial blood pressure (ABP) and respiratory responses to scoleces extract before (Panel A) and after (Panel B) treatment with the antihistamine antazoline. The duration between the two tests was 48 hours. Note that antazoline did not abolish the responses.

EFFECTS OF HYDATID SCOLECES EXTRACT IN SHEEP 509 Effect of pretreatment with compound 48/80: Compound 48/80 successfully blocked the reactions to the scolex extract solution (fig. 4). Even as much as 8 ml extract solution failed to evoke any response in the compound-pretreated group. Gross postmortem examination of the liver and lungs dit not show any hydatid cyst. Fig. 4. Effect of compound 48/80 on the blockade of the reactions to 4 ml hydatid scoleces extract during the second test. During the first test (not shown here) 48 hours earlier, the sheep developed hypotension and shallow rapid respiration to scoleces extract injection. Discussion The saline extract of the ovine hydatid cyst scoleces has pronounced cardiovascular and respiratory effects in sheep. The elicited responses are similar to those brought about by the hydatid cyst fluid administration to some laboratory animals (7-10). Annales de Parasitologie humaine et comparée (Paris), t. 55, n 5 35

510 M. TABATABAI, M. VESSAL AND N. COHANIM Atropine did not block the reactions to the extract, suggesting that the extract dit not contain acetylcholine or other parasympathomimetic agents. Compound 48/80, a histamine releaser (4) abolished the reactions to the scolex extract, showing that the action of the extract was through the release of histamine from the tissues in the body. In support of this conclusion is the observation that subsequent injections of the extract during the same test produced a lesser hypotensive response or none at all (fig. 1), indicating that the extract decreased or depleted the body contents of histamine on the first injection, so that during the second injection less or no histamine was released. Histamine release by the extract, however, may be a direct effect or it may be brought about by antigen-antibody reaction. If the responses to the extract are due to the release of histamine, the question arises as to why the antihistamine antazoline failed to prevent the responses to the extract. It is conceivable to assume that the amount of histamine released was more than what could be blocked by the amount of antazoline administered. In line with the results of the present investigation, we have shown that the responses to hydatid cyst fluid administration cannot be blocked by pretreatment with atropine or antihistamines (9, 10), but can be prevented by pretreatment with compound 48/80 (unpublished data). References 1. Brown H.W.: Chapter on «Diseases caused by metazoa» in P. B. Beeson and W. McDermott, «Cecil and Loeb Textbook of Medicine», pp. 421-423. W.B. Saunders Company, Philadelphia and London, 1963. 2. Dew H. R.: Hydatid Disease: Its Pathology, Diagnosis and Treatment. Australian Medical Publishing Company, Sydney, 1928. 3. Dibello R., Menendez H.: Intracardiac rupture of hydatid cyst of the heart. A study based on three personal observations and 101 cases in the world literature. Circulation, 1963, 27, 366-374. 4. Douglas W. W.: Histamine and Antihistamines, pp. 590-613. In Goodman L. S., Gilman A., Eds.: The Pharmacological Basis of Therapeutics. Fifth edition, Macmillan Publishing Co., New York, 1975. 5. Handjani A. M., Farpour A., Mechanic K., Haghighat A., Dutz W.: Cardiovascular echinococcosis. Am. J. Surg., 1969, 117, 666-670. 6. Rocha e Silva M., Grana A. : Shock produced in dogs by hydatid fluid. Am. J. Physiol., 1945, 143, 306-313. 7. Tabatabai M., Boroomand K., Gettner S. : Respiratory and cardiovascular responses resulting from intravenous injection of sheep hydatid cyst fluid to dogs. Exp. Parasitol., 1973, 34, 12-21. 8. Tabatabai M., Etemadi A. A., Cohanim N.: Shock induced in cats by intravenous injection of ovine hydatid cyst fluid. Pahlavi Med. J., 1973, 4, 398-416. 9. Tabatabai M., Ismaili M. H., Nazarian I., Daneshbod K.: Pathophysiological changes resulting from intravenous injection of ovine hydatid cyst fluid to sheep. Br. J. Exp. Pathol., 1974, 55, 33-37. 10. Tabatabai M., Ismaili M. H., Sami M., Fardin R., Kadivar R.: Effect of ovine hydatid cyst fluid on the cardiovascular and respiratory systems in sheep. Ann. Parasitol. Hum. Comp., 1975, 50, 7-15.